What were the key takeaways from RCM Technologies’s earnings call?

What is RCM Technologies's latest dividend and current dividend yield?

What is the market's earnings forecast for RCM Technologies next quarter?

Did RCM Technologies beat or miss consensus estimates last quarter?

What does RCM Technologies do and what are its main business segments?

What guidance did RCM Technologies's management provide for the next earnings period?

What is the revenue and EPS growth rate for RCM Technologies year over year?

What is RCM Technologies's gross profit margin?

- **Record Engineering Backlog**: $70M for 2026, up from $21M in 2024, driven by Energy Services.
- **Healthcare Growth**: 20.7% school revenue increase, new partnerships, and 2026 pipeline momentum.
- **Medical Cost Challenges**: $1.8M over budget YTD, with no immediate relief beyond 2026 measures.
- **Aerospace/Defense Surge**: 45% revenue growth, 110% EBITDA rise, and Bell Flight's Best New Supplier award.
- **AI and Digital Innovation**: Life Sciences AI compliance, predictive analytics, and 3D BIM in engineering.

**【Management Opening Remarks】**
- Kevin Miller provided standard disclaimers about forward-looking statements.
- Brad Vizi highlighted record 2026 engineering backlog and healthcare momentum, despite $1.8M in excess medical costs year-to-date.

**【CEO Business Unit Updates】**
- **Healthcare**: 20.7% growth in school revenue, new school partners, and broadened client roles. Anticipates 2026 benefits from a foreign recruitment pipeline.
- **Life Sciences**: AI-driven compliance streamlines protocols; dedicated engineering group and AI analytics for predictive forecasting.
- **Engineering**: Energy Services achieved $70M 2026 backlog, outpacing 2024's $21M. Aerospace/Defense saw 45% revenue growth, 49% gross profit increase, and 110% EBITDA rise.
- **Talent Attraction**: Increased qualified candidates, driven by brand strength and digital presence.

**【CFO Financial Commentary】**
- **Consolidated Results**: Q3 2025 gross profit up 8.8% to $19.4M; adjusted EBITDA $5.5M (-1.4% YoY). Healthcare gross profit +8.5%, Engineering +17.3% (record high).
- **Challenges**: $1.8M over budget medical claims; Q3 cash flow issues with 2 large clients.
- **Q4 Outlook**: Highest quarterly gross profit and EBITDA expected, with focus on 2026 backlog growth.

**【Q&A Highlights】**
- **Foreign Nurses**: 300+ nurses in pipeline, visa timeline uncertain; 50-60 potential arrivals if dates move 3-4 months.
- **Medical Costs**: $1.8M over budget YTD; 2026 cost reduction measures in early stages.
- **Engineering Growth**: Focus on Tier 1 utilities; interconnect projects for data centers.
- **Capital Allocation**: Share buybacks cautious; dividend consideration ongoing.
- **Talent Strategy**: Digital brand investment attracts top talent, especially in engineering and healthcare.

RCMT

RCMT fundamentals

You can ask Aime